Aller au contenu principal
Profil bibliographique

Robert O. Williams

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

440Publications signalées
17161Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Drug Solubulity and Delivery SystemsInhalation and Respiratory Drug DeliveryAdvanced Drug Delivery SystemsMicroencapsulation and Drying ProcessesProtein purification and stability

Les publications récentes

Accès ouvert 2026 article OpenAlex

From Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma

Alexandra M. L. Oliveira, Maria Raposo, Sorawee Yanwinitchai, Robert O. Williams et autres

Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibroblast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces intended to enable localized release …

pt, us, dk (code pays fourni par la source)

0 citations International Journal of Molecular Sciences
Accès ouvert 2026 preprint OpenAlex

From Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma

Alexandra M. L. Oliveira, Maria Raposo, Sorawee Yanwinitchai, Robert O. Williams et autres

Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibro-blast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces that enables localized release of …

0 citations Preprints.org
Accès ouvert 2025 article OpenAlex

Controlled release and extended pulmonary retention of inhaled therapeutics: A review

Sorawee Yanwinitchai, Robert O. Williams

The advancement of controlled release systems for pulmonary therapeutic products has become a significant focus in pharmaceutical research. Various strategies have been employed to regulate the release rate of therapeutic agents, targeting both the release enhancement of poorly water-soluble drugs and prolonging …

us (code pays fourni par la source)

6 citations European Journal of Pharmaceutical Sciences
Accès ouvert 2025 article OpenAlex

p53-miR-34a feedback in lung fibroblasts regulates antifibrotic effects of CSP7, nintedanib, and pirfenidone

Liang Fan, Rashmi S. Shetty, Huy M. Dao, Akarsha Balnadupete et autres

Pulmonary fibrosis is a progressive and fatal fibroproliferative disease. The current drugs (nintedanib/pirfenidone) only slow clinical progression. Myofibroblasts are the primary effector cells of PF. We found that CSP7, nintedanib and pirfenidone exert antifibrotic effects through restoring p53-microRNA-34a feedback induction in lung …

us (code pays fourni par la source)

3 citations American Journal of Physiology-Lung Cellular and Molecular Physiology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.